Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Christopher D Pack

Showing results (11-20 of 20) with videos related to

Pageof 2
Sort By:
You have reached the last page of results.This site can display upto 20 results.
International Journal of Molecular Sciences|August 27, 2021
Dendritic Cells Pulsed with Cytokine-Adjuvanted Tumor Membrane Vesicles Inhibit Tumor Growth in HER2-Positive and Triple Negative Breast Cancer ModelsLuis E Munoz, Lenore Monterroza, Ramireddy Bommireddy, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 10, 2007
The antiviral CD8+ T cell response is differentially dependent on CD4+ T cell help over the course of persistent infectionChristopher C Kemball, Christopher D Pack, Heath M Guay, et al.
Biomaterials|October 14, 2015
Plasma membrane vesicles decorated with glycolipid-anchored antigens and adjuvants via protein transfer as an antigen delivery platform for inhibition of tumor growthJaina M Patel, Vincent F Vartabedian, Erica N Bozeman, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 27, 2012
CD8 T cells recruited early in mouse polyomavirus infection undergo exhaustionJarad J Wilson, Christopher D Pack, Eugene Lin, et al.
Journal for Immunotherapy of Cancer|November 24, 2021
Metformin reduces PD-L1 on tumor cells and enhances the anti-tumor immune response generated by vaccine immunotherapyLuis Enrique Munoz, Lei Huang, Ramireddy Bommireddy, et al.
Human Vaccines & Immunotherapeutics|June 13, 2020
Tumor membrane-based vaccine immunotherapy in combination with anti-CTLA-4 antibody confers protection against immune checkpoint resistant murine triple-negative breast cancerChristopher D Pack, Ramireddy Bommireddy, Luis E Munoz, et al.
Journal of Virology|July 22, 2011
Gamma interferon controls mouse polyomavirus infection in vivoJarad J Wilson, Eugene Lin, Christopher D Pack, et al.
Immunity & Ageing : I & A|May 11, 2023
Hemagglutinin virus-like particles incorporated with membrane-bound cytokine adjuvants provide protection against homologous and heterologous influenza virus challenge in aged miceBo Ryoung Park, Ramireddy Bommireddy, David Hyunjung Chung, et al.
Vaccines|April 17, 2020
Tumor Membrane Vesicle Vaccine Augments the Efficacy of Anti-PD1 Antibody in Immune Checkpoint Inhibitor-Resistant Squamous Cell Carcinoma Models of Head and Neck CancerRamireddy Bommireddy, Luis E Munoz, Anita Kumari, et al.
Vaccines|June 24, 2022
Influenza Virus-like Particle-Based Hybrid Vaccine Containing RBD Induces Immunity against Influenza and SARS-CoV-2 VirusesRamireddy Bommireddy, Shannon Stone, Noopur Bhatnagar, et al.
Pageof 2

Showing results (11-20 of 20) with videos related to

Sort By:
Pageof 2
You have reached the last page of results.This site can display upto 20 results.
International Journal of Molecular Sciences|August 27, 2021
Dendritic Cells Pulsed with Cytokine-Adjuvanted Tumor Membrane Vesicles Inhibit Tumor Growth in HER2-Positive and Triple Negative Breast Cancer ModelsLuis E Munoz, Lenore Monterroza, Ramireddy Bommireddy, et al.
Journal of Immunology (Baltimore, Md. : 1950)|July 10, 2007
The antiviral CD8+ T cell response is differentially dependent on CD4+ T cell help over the course of persistent infectionChristopher C Kemball, Christopher D Pack, Heath M Guay, et al.
Biomaterials|October 14, 2015
Plasma membrane vesicles decorated with glycolipid-anchored antigens and adjuvants via protein transfer as an antigen delivery platform for inhibition of tumor growthJaina M Patel, Vincent F Vartabedian, Erica N Bozeman, et al.
Journal of Immunology (Baltimore, Md. : 1950)|March 27, 2012
CD8 T cells recruited early in mouse polyomavirus infection undergo exhaustionJarad J Wilson, Christopher D Pack, Eugene Lin, et al.
Journal for Immunotherapy of Cancer|November 24, 2021
Metformin reduces PD-L1 on tumor cells and enhances the anti-tumor immune response generated by vaccine immunotherapyLuis Enrique Munoz, Lei Huang, Ramireddy Bommireddy, et al.
Human Vaccines & Immunotherapeutics|June 13, 2020
Tumor membrane-based vaccine immunotherapy in combination with anti-CTLA-4 antibody confers protection against immune checkpoint resistant murine triple-negative breast cancerChristopher D Pack, Ramireddy Bommireddy, Luis E Munoz, et al.
Journal of Virology|July 22, 2011
Gamma interferon controls mouse polyomavirus infection in vivoJarad J Wilson, Eugene Lin, Christopher D Pack, et al.
Immunity & Ageing : I & A|May 11, 2023
Hemagglutinin virus-like particles incorporated with membrane-bound cytokine adjuvants provide protection against homologous and heterologous influenza virus challenge in aged miceBo Ryoung Park, Ramireddy Bommireddy, David Hyunjung Chung, et al.
Vaccines|April 17, 2020
Tumor Membrane Vesicle Vaccine Augments the Efficacy of Anti-PD1 Antibody in Immune Checkpoint Inhibitor-Resistant Squamous Cell Carcinoma Models of Head and Neck CancerRamireddy Bommireddy, Luis E Munoz, Anita Kumari, et al.
Vaccines|June 24, 2022
Influenza Virus-like Particle-Based Hybrid Vaccine Containing RBD Induces Immunity against Influenza and SARS-CoV-2 VirusesRamireddy Bommireddy, Shannon Stone, Noopur Bhatnagar, et al.
Pageof 2